… Several studies have investigated the inhibitory effects of molnupiravir on COVID-19 replication
… in the future to confirm the therapeutic effects of molnupiravir in patients with COVID-19. …

… Finally, cost effectiveness and accessibility for all is a major issue that needs to be dealt
with and effect of molnupiravir with other therapies for COVID-19 needs to be examined. The …

… However, a Phase 2/3 study is ongoing to evaluate the effect of molnupiravir on symptom
duration and severity, emergency department visits, and hospitalizations (ClinicalTrials.gov …

… of molnupiravir for the treatment of mild to moderate COVID-19 … and COVID-19–related
acute care visits were evaluated in all randomly assigned participants who received molnupiravir …

… the placebo and Molnupiravir groups, and a random effect, … infected individual receives the
Molnupiravir treatment on day … of COVID-19 is 5 and all infected people take the Molnupiravir …

… trials, molnupiravir showed beneficial effects for … molnupiravir are also summarized and
discussed, aiming to expand our knowledge on molnupiravir and better deal with the COVID-19 …

… The therapeutic effect of molnupiravir can be described based on its 2-step mutagenesis
mechanism. In the first step, RdRp uses positive-strand genomic RNA +gRNA to synthesize a …

… In this study, the treatment effect estimates for the primary end point, which was the rate
of hospitalization or death through day 29, was reduced in the all-randomized analysis as …

… To evaluate molnupiravir’s effect on viral RNA error rates, nasopharyngeal samples
containing >22,000 copies/ml of SARS-CoV-2 RNA underwent complete genome next-generation …

… of treatment with molnupiravir started … Covid-19 and at least one risk factor for severe
Covid-19 illness. Participants in the trial were randomly assigned to receive 800 mg of molnupiravir …